Nasal glial heterotopia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141112Q30.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Nasal glial heterotopia, also commonly known as nasal glioma, is a rare congenital developmental malformation consisting of ectopic brain tissue (glial tissue) located in or around the nose. Despite the term 'glioma,' this condition is not a true neoplasm but rather a developmental anomaly resulting from sequestration of glial tissue outside the cranial cavity during embryonic development. It is thought to represent a form of encephalocele that has lost its intracranial connection, though in some cases a fibrous stalk connecting to the dura mater may persist. Nasal glial heterotopia typically presents at birth or in early infancy as a firm, non-compressible mass located either externally on the nasal bridge (extranasal, approximately 60% of cases), within the nasal cavity (intranasal, approximately 30%), or in a combined location (approximately 10%). External lesions appear as smooth, firm, skin-covered masses near the root of the nose, sometimes with a bluish discoloration. Intranasal lesions may cause nasal obstruction, difficulty breathing (especially in neonates who are obligate nasal breathers), and feeding difficulties. The mass does not transilluminate and does not increase in size with crying or straining (Furstenberg test negative), which helps distinguish it from an encephalocele. Rarely, the condition may be associated with other craniofacial anomalies. Diagnosis is established through clinical examination, imaging studies (CT and MRI are essential to evaluate any intracranial connection and to differentiate from encephalocele), and histopathological confirmation showing mature glial tissue with astrocytes embedded in a fibrous connective tissue matrix. Treatment is primarily surgical excision, which is both diagnostic and curative. Complete surgical removal is important to prevent recurrence, which occurs in approximately 10% of incompletely excised cases. Prognosis after complete excision is excellent, with no risk of malignant transformation. Preoperative imaging is critical to rule out intracranial communication before any surgical intervention is attempted.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Nasal glial heterotopia.

View clinical trials →

No actively recruiting trials found for Nasal glial heterotopia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Nasal glial heterotopia community →

No specialists are currently listed for Nasal glial heterotopia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Nasal glial heterotopia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nasal glial heterotopiaForum →

No community posts yet. Be the first to share your experience with Nasal glial heterotopia.

Start the conversation →

Latest news about Nasal glial heterotopia

No recent news articles for Nasal glial heterotopia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Nasal glial heterotopia

What is Nasal glial heterotopia?

Nasal glial heterotopia, also commonly known as nasal glioma, is a rare congenital developmental malformation consisting of ectopic brain tissue (glial tissue) located in or around the nose. Despite the term 'glioma,' this condition is not a true neoplasm but rather a developmental anomaly resulting from sequestration of glial tissue outside the cranial cavity during embryonic development. It is thought to represent a form of encephalocele that has lost its intracranial connection, though in some cases a fibrous stalk connecting to the dura mater may persist. Nasal glial heterotopia typically

How is Nasal glial heterotopia inherited?

Nasal glial heterotopia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Nasal glial heterotopia typically begin?

Typical onset of Nasal glial heterotopia is neonatal. Age of onset can vary across affected individuals.